Literature DB >> 7924827

Nicotinamide treatment in the prevention of insulin-dependent diabetes mellitus.

T Mandrup-Poulsen1, J I Reimers, H U Andersen, F Pociot, A E Karlsen, U Bjerre, J Nerup.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7924827     DOI： 10.1002/dmr.5610090410

Source DB:  PubMed          Journal:  Diabetes Metab Rev        ISSN： 0742-4221


× No keyword cloud information.
  6 in total

1.  Nicotinamide improves motor deficits and upregulates PGC-1α and BDNF gene expression in a mouse model of Huntington's disease.

Authors:  Tyisha Hathorn; Abigail Snyder-Keller; Anne Messer
Journal:  Neurobiol Dis       Date:  2010-08-22       Impact factor: 5.996

Review 2.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

Review 3.  Medical care from childhood to adulthood in type 1 and type 2 diabetes.

Authors:  G Costi; S Ten; N K Maclaren
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 4.256

4.  Intervening before the onset of Type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT).

Authors: 
Journal:  Diabetologia       Date:  2003-02-27       Impact factor: 10.122

5.  Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes.

Authors:  A A Pieper; D J Brat; D K Krug; C C Watkins; A Gupta; S Blackshaw; A Verma; Z Q Wang; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

6.  Inhibition of poly(ADP-ribose) polymerase activity is insufficient to induce tetraploidy.

Authors:  C M Simbulan-Rosenthal; D S Rosenthal; R Luo; J H Li; J Zhang; M E Smulson
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.